Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Morristown, NJ
SEC filing record 1 source field available
Fiscal year end
31 December
Whitehawk Therapeutics, Inc. has filed 652 SEC EDGAR filings since 01 Feb 2008

SEC filing history

Showing 301-325 of 638 matching filings.

Per page
25
Current page
13
4

FORM 4 SUBMISSION

Filing date
10 Sep 2021
Reporting date
08 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
10 Sep 2021
Reporting date
08 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-412879

D filing

Filing date
10 Sep 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-412878

D filing

Filing date
10 Sep 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-83932

SC 13D

Filing date
08 Sep 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-83932

SC 13G filing

Filing date
07 Sep 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-83932

AADI BIOSCIENCE, INC.

Filing date
07 Sep 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-83932

AMENDMENT NO. 3

Filing date
03 Sep 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-83932

SCHEDULE 13G

Filing date
02 Sep 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
31 Aug 2021
Reporting date
27 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
31 Aug 2021
Reporting date
27 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
31 Aug 2021
Reporting date
26 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
31 Aug 2021
Reporting date
26 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
31 Aug 2021
Reporting date
26 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
31 Aug 2021
Reporting date
26 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A SUBMISSION

Filing date
31 Aug 2021
Reporting date
26 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
30 Aug 2021
Reporting date
26 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
30 Aug 2021
Reporting date
26 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
30 Aug 2021
Reporting date
26 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
30 Aug 2021
Reporting date
26 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-83932

AADI BIOSCIENCE, INC.

Filing date
30 Aug 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-83932

AERPIO PHARMACEUTICALS, INC.

Filing date
23 Aug 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .